Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Work In Process: 2016-2017

Historic Work In Process for Amicus Therapeutics (FOLD) over the last 2 years, with Dec 2017 value amounting to $3.8 million.

  • Amicus Therapeutics' Work In Process rose 107.46% to $7.2 million in Q1 2018 from the same period last year, while for Mar 2018 it was $7.2 million, marking a year-over-year increase of 107.46%. This contributed to the annual value of $3.8 million for FY2017, which is 16.17% up from last year.
  • Per Amicus Therapeutics' latest filing, its Work In Process stood at $3.8 million for FY2017, which was up 16.17% from $3.3 million recorded in FY2016.
  • Amicus Therapeutics' Work In Process' 5-year high stood at $3.8 million during FY2017, with a 5-year trough of $3.3 million in FY2016.
  • In the last 2 years, Amicus Therapeutics' Work In Process had a median value of $3.6 million in 2016 and averaged $3.6 million.
  • Data for Amicus Therapeutics' Work In Process shows a peak YoY climbed of 16.17% (in 2017) over the last 5 years.
  • Amicus Therapeutics' Work In Process (Yearly) stood at $3.3 million in 2016, then climbed by 16.17% to $3.8 million in 2017.